Toxicities
Showing 1 - 25 of >10,000
Toxicities in Gastrointestinal and Sarcomatous Malignancies
Not yet recruiting
- Sarcoma
- Gastrointestinal Cancer
- Survey
- Toxicity Assessments
- (no location specified)
Feb 23, 2023
Radio-induced Toxicities in Treatment of Lung Cancer With
Not yet recruiting
- Lung Cancer
-
Metz, FranceCHR Metz-Thionville/Hopital de Mercy
Jun 5, 2023
Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)
Recruiting
- Renal Cell Carcinoma
- +3 more
- Arterial Doppler for Flow Mediated Reserve measurement
-
Paris, FranceINstitut Mutualiste Montsouris
Aug 29, 2023
Toxicities of Salvage Treatment in Locoregionally Recurrent
Not yet recruiting
- Breast Cancer
- Salvage treatment (surgery and/or radiation therapy)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 5, 2023
Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Knoxville (Pencil Beam Scanning Proton Therapy)
Recruiting
- Breast Cancer
- +3 more
- Pencil Beam Scanning Proton Therapy
-
Knoxville, TennesseeThompson Proton Center
Aug 17, 2023
Toxicities in Soft Tissue Sarcoma of the Extremities - Cohort B
Recruiting
- Soft Tissue Sarcoma of the Extremities
-
Cambridge, United Kingdom
- +2 more
Jul 27, 2023
Toxicities on Health During Cancer
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Assessment of Therapy Complications
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 16, 2023
Xiao Chai Hu Tang, Irinotecan-induced Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Placebo, FOLFIRI/mXELIRI regimen)
Not yet recruiting
- Xiao Chai Hu Tang
- Irinotecan-induced Diarrhea
- Xiao Chai Hu Tang (XCHT)
- +3 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Traditional Chinese Medicine
Sep 24, 2023
Toxicities in Children and Adults With Cancer
Active, not recruiting
- Macrophage Activation Syndrome
- Primary Hemophagocytic Lymphohistiocytosis
-
Bethesda, MarylandNational Cancer Institute (NCI)
Sep 17, 2022
Fasting, Diet, Chemo, Toxicity Trial in Tríkala (fasting diet)
Recruiting
- Fasting, Diet, Chemotherapy, Toxicity
- fasting diet
-
Tríkala, Thessaly, GreeceDepartment of Nutrition-Dietetics
Aug 27, 2023
Understanding immunE-related toXicities by multifACeT Profiling
Recruiting
- Oncology
-
Chelsea, London, United KingdomRoyal Marsden NHS Foundation Trust
Apr 21, 2022
Breast Cancer, Peripheral Neuropathy, Cardiac Toxicities Trial in Tanta (Silymarin, Placebo)
Enrolling by invitation
- Breast Cancer
- +4 more
- Silymarin
- Placebo
-
Tanta, EgyptTanta university
Oct 22, 2022
Malignant Tumors Trial in New York (No intervention)
Not yet recruiting
- Malignant Neoplasms
- No intervention
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 7, 2022
Colo-rectal Cancer, Neuropathy;Peripheral, Mucositis Trial in Tanta (Pentoxifylline, Placebo, FOLFOX-6 regimen)
Enrolling by invitation
- Colo-rectal Cancer
- +2 more
- Pentoxifylline
- +2 more
-
Tanta, Gharbyia, EgyptTanta University
Oct 18, 2022
Reporting of Antibody-Drug Conjugate Associated Sepsis-related
Completed
- Sepsis (SMQ)
- +2 more
- Antibody-Drug Conjugate
- Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
-
Changsha, Hunan, ChinaCentral South University
Jun 19, 2022
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%
Not yet recruiting
- Acneiform Eruption Due to Chemical
- +2 more
- HT-001 2% Topical Gel
- +3 more
- (no location specified)
Dec 3, 2022
Peripheral Blood Proteomics to Predict Treatment Response and
Recruiting
- Non Small Cell Lung Cancer
- Blood draw
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
May 10, 2022
Late Toxicities After Radiotherapy in Breast and Prostate Cancer
Completed
- Breast Cancer
- Prostate Cancer
-
Montpellier, FranceCRLC Val d'Aurelle
Nov 29, 2022
Resistance Training, Colon Cancer, Chemo Effect Trial in Oakland, Boston, Hershey (Resistance training)
Completed
- Resistance Training
- +2 more
- Resistance training
-
Oakland, California
- +2 more
Jul 27, 2022
Prior Blinatumomab on Subsequent CD19 CAR Outcomes and
Active, not recruiting
- Leukemia, Acute Lymphoblastic
- Lymphoblastic Leukemia, Acute, Childhood
-
Bethesda, MarylandNational Cancer Institute (NCI)
Aug 13, 2022
Malignant Tumor, Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Raloxifene, FOLFIRI regimen)
Recruiting
- Malignant Tumor
- Diarrhea
- Xiao Chai Hu Tang (XCHT)
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
Aug 11, 2022
Cervical Carcinoma, Endometrial Carcinoma, Endometriosis Trial in Scottsdale, Jacksonville, Rochester (Quality-of-Life
Recruiting
- Cervical Carcinoma
- +3 more
- Quality-of-Life Assessment
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023
Cancer, Radiotherapy Side Effect Trial in Montreal (Radiotherapy)
Recruiting
- Cancer
- Radiotherapy Side Effect
- Radiotherapy
-
Montreal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Mar 14, 2022
Cancer Trial in Montpellier, Nîmes (THESS monitoring)
Not yet recruiting
- Cancer
- THESS monitoring
-
Montpellier, France
- +2 more
Apr 25, 2022
Acute Leukemia, Myelodysplastic Syndrome Trial in Duarte (Hematopoietic Cell Transplantation, Intensity-Modulated Radiation
Recruiting
- Acute Leukemia
- Myelodysplastic Syndrome
- Hematopoietic Cell Transplantation
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022